Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Atenolol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 26Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Health Canada Issues Recall of Teva-Atenolol 50mg due incorrect product image on the label
    Health Canada Issues Recall of Teva-Atenolol 50mg due incorrect product image on the label

    21 Nov 2022

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/recall-teva-atenolol-50mg-due-incorrect-product-image-label

    HEALTH CANADA
    21 Nov 2022
    Share Share
    Enforcement Report - Week of November 2, 2022
    Enforcement Report - Week of November 2, 2022

    02 Nov 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-2-2022-77418.pdf

    FDA
    02 Nov 2022
    Share Share
    Quantification of Compatibility Between Polymeric Excipients and Atenolol
    Quantification of Compatibility Between Polymeric Excipients and Atenolol

    26 Nov 2021

    // PHARMAEXCIPIENTS

    https://www.pharmaexcipients.com/news/compatibiliy-polymeric-excipients-atenolol/

    PHARMAEXCIPIENTS
    26 Nov 2021
    Share Share
    Novitium Pharma’s Generics Atenolol; Chlorthalidone Receives Approvals In US
    Novitium Pharma’s Generics Atenolol; Chlorthalidone Receives Approvals In US

    28 Oct 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215560

    FDA
    28 Oct 2021
    Share Share
    Unichem Labs receives ANDA approval for Atenolol and Chlorthalidone tablets
    Unichem Labs receives ANDA approval for Atenolol and Chlorthalidone tablets

    29 Nov 2020

    // J. Jagannath LIVEMINT

    https://www.livemint.com/companies/news/unichem-labs-receives-anda-approval-for-atenolol-and-chlorthalidone-tablets-11606639120793.html

    J. Jagannath LIVEMINT
    29 Nov 2020
    Share Share
    AstraZeneca hawks suite of hypertension drugs for $350M in latest asset sale
    AstraZeneca hawks suite of hypertension drugs for $350M in latest asset sale

    03 Mar 2020

    // K. Blankenship FIERCE PHARMA

    https://www.fiercepharma.com/pharma/astrazeneca-hawks-suite-hyptertension-drugs-for-350m-latest-asset-sale

    K. Blankenship FIERCE PHARMA
    03 Mar 2020
    Share Share